Picture of Bioventus logo

BVS Bioventus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Bioventus Inc expected to post earnings of 18  cents a share - Earnings Preview

* Bioventus Inc  BVS.OQ   BVS.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 10. 
    * The Durham North Carolina-based  company is expected to
report 
a 32.2% increase in revenue to $130.29 million from $98.59
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bioventus Inc is
for
earnings of 18 cents per share. For the same quarter last year,
the company reported earnings of $2.32 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioventus
Inc is
$20​, about 33.6% above​ its last closing price of $13.29. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.14        0.14       0.25      Beat    78.6
 Jun. 30 2021  0.10        0.14       0.16      Beat    16.4
 Mar. 31 2021  0.10        0.10       0.15      Beat    57.9​
 Dec. 31 2020  0.23        0.23       2.32      Beat    908.7
 ​​                                                     
                                                        ​
 This summary was machine generated March 8 at 14:27 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bioventus

See all news